Treatment Posts on Medivizor
Navigation Menu

Treatment Posts on Medivizor

Incobotulinumtoxin A in the treatment of excessive salivation in patients with neurological conditions

Posted by on Apr 19, 2019 in Stroke | 0 comments

In a nutshell This study investigated the effectiveness and safety of incobotulinumtoxinA (IBTA) for the treatment of excessive salivation (sialorrhea) in patients with Parkinson's disease or stroke. Researchers suggested that IBTA might be a well-tolerated option for the treatment of these patients. Some background Sialorrhea (excessive...

Read More

Evaluating ixazomib maintenance therapy for patients with multiple myeloma

Posted by on Apr 19, 2019 in Multiple Myeloma | 0 comments

In a nutshell This study evaluated the safety and effectiveness of ixazomib (Ninlaro) given after a stem cell transplant for patients with multiple myeloma (MM). This study concluded that ixazomib maintenance therapy is effective for these patients, with manageable side effects. Some background Multiple myeloma is a type of cancer of the bone marrow...

Read More

Which treatment is safer and more effective for overactive bladder, onabotulinumtoxinA or mirabegron?

Posted by on Apr 18, 2019 in Overactive bladder | 0 comments

In a nutshell This study compared how safe and effective onabotulinumtoxinA (Botox) and mirabegron are in treating overactive bladder. The authors concluded botox is more effective in the treatment of overactive bladder symptoms. Some background Overactive bladder (OAB) is a common syndrome. Symptoms include urinary urgency, frequency, and urine...

Read More

Combining pracinostat and azacitidine to treat older patients with newly diagnosed acute myeloid leukemia

Posted by on Apr 15, 2019 in Leukemia | 0 comments

In a nutshell This study aimed to investigate the safety and effectiveness of the combination of pracinostat and azacitidine in patients aged over 65 with newly diagnosed acute myeloid leukemia. This study concluded that this combination is a safe and effective for treating this group of patients.   Some background Pracinostat is a new drug that...

Read More

Evaluating long-term outcomes after radiation and stem cell transplantation for recurrent or unresponsive Hodgkin lymphoma

Posted by on Apr 15, 2019 in Hodgkin's lymphoma | 0 comments

In a nutshell This study evaluated the long-term outcomes of patients with recurrent or non-responsive classical Hodgkin’s lymphoma (cHL) after undergoing radiation, chemotherapy, and autologous stem cell transplantation (autoSCT). This study concluded that total lymphoid irradiation (TLI) therapy before a bone marrow transplant can improve...

Read More

The effect of semaglutide versus sitagliptin as add-on therapy for type 2 diabetes

Posted by on Apr 13, 2019 in Diabetes mellitus | 0 comments

In a nutshell The aim of this study was to compare the effects of adding semaglutide versus sitagliptin onto metformin with or without a sulfonylurea in type 2 diabetes (T2D). The main finding was that adding 7mg or 14mg semaglutide on to metformin/sulphonylurea therapy showed greater improvements in blood sugar control compared to sitagliptin. Some...

Read More

Computer training improves arm function in patients with stroke

Posted by on Apr 13, 2019 in Stroke | 0 comments

In a nutshell The aim of this study was to examine the effect of MyoCI training on arm recovery in patients who had a stroke. The main finding of the study was that MyoCI training reduced abnormal arm activation in these patients. Some background About 60% of stroke survivors have an arm impairment. This impairment is caused by weakness, muscles...

Read More